RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

A new anti-HER2 IgE antibody potentially offers new therapy options for treatment-resistant breast and ovarian cancers.

Cell-free systems, which can express an easily detectable protein with a DNA or mRNA template without constraints of living ...

CD163 might not be the most exciting name in the world, but behind it lies one of the body's most important defense receptors ...